e-learning
resources
Paris 2018
Sunday, 16.09.2018
Innovative therapies in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of doxofylline in COPD: a pair-wise meta-analysis
M. Cazzola (Rome, Italy), L. Calzetta (Rome, Italy), P. Rogliani (Rome, Italy), C. Page (London, United Kingdom), M. Matera (Naples, Italy)
Source:
International Congress 2018 – Innovative therapies in asthma and COPD
Session:
Innovative therapies in asthma and COPD
Session type:
Poster Discussion
Number:
616
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Cazzola (Rome, Italy), L. Calzetta (Rome, Italy), P. Rogliani (Rome, Italy), C. Page (London, United Kingdom), M. Matera (Naples, Italy). Impact of doxofylline in COPD: a pair-wise meta-analysis. 616
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Efficacy and safety profile of xanthines in COPD: a network meta-analysis
Source: Eur Respir Rev, 27 (148) 180010; 10.1183/16000617.0010-2018
Year: 2018
Efficacy and safety profile of xanthines in COPD: a network meta-analysis
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018
Prevalence of COPD: updated meta-analysis results
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007
Job strain and COPD exacerbations: an individual-participant meta-analysis
Source: Eur Respir J 2014; 44: 247-251
Year: 2014
Comparative efficacy of umeclidinium/vilanterol versus LABA/LAMA therapies in COPD: A network meta-analysis
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017
Risk of pneumonia related to budesonide use in COPD: An updated pooled analysis
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012
Cardiac events among patients with CV comorbidities: Pooled analysis of COPD trials comparing tiotropium with salmeterol
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial
Source: International Congress 2018 – COPD management
Year: 2018
Comparison of cardiovascular safety in a pooled analysis of COPD trials comparing tiotropium with salmeterol
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Combined tiotropium + olodaterol influences physical functioning in COPD: Results of an open-label observational study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study
Source: Eur Respir J 2010; 35: 532-539
Year: 2010
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Efficacy of psychosocial intervention in COPD: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept